Exploring the patient dynamic from different perspectives
While it seems fairly obvious that drug development is centred on the patient, the truth is that patients were not always an integral part of the process. Perhaps more importantly, patients were not involved in the conversation as to whether the drugs being developed would actually be beneficial and improve the patient’s quality of life.
In early 2020, ICON invited distinguished speakers; Avril Daly, Vice President of EURORDIS (Patient Advocacy), Professor Orla Hardimann, Consultant Neurologist (Clinical Investigator) Dr. Anthony Yanni, Astellas Pharma (Pharmaceutical Executive) to participate in a panel discussion, chaired by Dr. Nuala Murphy. The panellists discussed the dynamics of patient centricity in clinical research from their diverse stakeholder positions.
A report outlining the challenges and potential solutions of integrating patient insight for improved outcomes.
Vice President of EURORDIS and CEO of Retina International
Senior Vice President and Global Head of Patient Centricity, Astellas Pharma
Professor of Neurology, Trinity College Dublin and Consultant Neurologist, Beaumont Hospital
President, Clinical Research Services, ICON plc